Elevated Capital Advisors
LH icon

Elevated Capital Advisors’s Labcorp LH Stock Holding History

Elevated Capital Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$308 Hold
1
– – ﹤0.01% 844
2026
Q2 		$280 Hold
1
– – ﹤0.01% 825
2026
Q1 		$267 Hold
1
– – ﹤0.01% 822
2025
Q4 		$251 Buy
+1
New +$266 ﹤0.01% 803

Other funds holding LH

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Elevated Capital Advisors's LH Position: Q3 2026 in Review

Elevated Capital Advisors held its Labcorp (LH) position steady in Q3 2026 at 1 share worth $308. The position accounts for ﹤0.01% of the portfolio, ranked #844.

Elevated Capital Advisors first reported a position in LH in Q4 2025 and has held it in 4 quarters since. 610 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Elevated Capital Advisors held 1 share of Labcorp worth $308 as of Q3 2026.
  • Elevated Capital Advisors left its Labcorp share count unchanged in Q3 2026.
  • Labcorp made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q3 2026, its #844 holding.
  • Elevated Capital Advisors first reported a position in Labcorp in Q4 2025 and has held it in 4 quarters since.
  • 610 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Elevated Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.